173 related articles for article (PubMed ID: 1684375)
1. Immunobiology of infection with recombinant vaccinia virus encoding murine IL-2. Mechanisms of rapid viral clearance in immunocompetent mice.
Karupiah G; Woodhams CE; Blanden RV; Ramshaw IA
J Immunol; 1991 Dec; 147(12):4327-32. PubMed ID: 1684375
[TBL] [Abstract][Full Text] [Related]
2. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2.
Karupiah G; Coupar BE; Andrew ME; Boyle DB; Phillips SM; Müllbacher A; Blanden RV; Ramshaw IA
J Immunol; 1990 Jan; 144(1):290-8. PubMed ID: 2295796
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 mediates potent antiviral responses via an interferon-dependent mechanism.
Foong YY; Jans DA; Rolph MS; Gahan ME; Mahalingam S
Virology; 2009 Oct; 393(2):228-37. PubMed ID: 19729181
[TBL] [Abstract][Full Text] [Related]
4. The role for host-immune factors in the in vivo antiviral effects of tumour necrosis factor.
Lidbury BA; Ramshaw IA; Sambhi SK
Cytokine; 1995 Feb; 7(2):157-64. PubMed ID: 7780035
[TBL] [Abstract][Full Text] [Related]
5. In vivo antiviral effect of interleukin 18 in a mouse model of vaccinia virus infection.
Tanaka-Kataoka M; Kunikata T; Takayama S; Iwaki K; Ohashi K; Ikeda M; Kurimoto M
Cytokine; 1999 Aug; 11(8):593-9. PubMed ID: 10433806
[TBL] [Abstract][Full Text] [Related]
6. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
[TBL] [Abstract][Full Text] [Related]
7. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Coupar BE; Andrew ME; Both GW; Boyle DB
Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
[TBL] [Abstract][Full Text] [Related]
8. Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma.
Kohonen-Corish MR; King NJ; Woodhams CE; Ramshaw IA
Eur J Immunol; 1990 Jan; 20(1):157-61. PubMed ID: 2106440
[TBL] [Abstract][Full Text] [Related]
9. Clearance of recombinant vaccinia virus expressing IL-2: role of local host immune responses.
Hügin AW; Flexner C; Moss B
Cell Immunol; 1993 Dec; 152(2):499-509. PubMed ID: 8258152
[TBL] [Abstract][Full Text] [Related]
10. T-bet is required for protection against vaccinia virus infection.
Matsui M; Moriya O; Yoshimoto T; Akatsuka T
J Virol; 2005 Oct; 79(20):12798-806. PubMed ID: 16188982
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo.
Bukowski JF; Woda BA; Habu S; Okumura K; Welsh RM
J Immunol; 1983 Sep; 131(3):1531-8. PubMed ID: 6309965
[TBL] [Abstract][Full Text] [Related]
12. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
13. Antiviral protection by CD8+ versus CD4+ T cells. CD8+ T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL.
Binder D; Kündig TM
J Immunol; 1991 Jun; 146(12):4301-7. PubMed ID: 1710246
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide production is increased during murine vaccinia virus infection, but may not be essential for virus clearance.
Rolph MS; Ramshaw IA; Rockett KA; Ruby J; Cowden WB
Virology; 1996 Mar; 217(2):470-7. PubMed ID: 8610438
[TBL] [Abstract][Full Text] [Related]
15. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).
Smith PM; Wolcott RM; Chervenak R; Jennings SR
Virology; 1994 Jul; 202(1):76-88. PubMed ID: 7912023
[TBL] [Abstract][Full Text] [Related]
16. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
Brutkiewicz RR; Klaus SJ; Welsh RM
Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
[TBL] [Abstract][Full Text] [Related]
17. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma.
Ruby J; Ramshaw I
Lymphokine Cytokine Res; 1991 Oct; 10(5):353-8. PubMed ID: 1768738
[TBL] [Abstract][Full Text] [Related]
18. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
Bohn E; Autenrieth IB
J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
[TBL] [Abstract][Full Text] [Related]
19. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria.
Yañez DM; Manning DD; Cooley AJ; Weidanz WP; van der Heyde HC
J Immunol; 1996 Aug; 157(4):1620-4. PubMed ID: 8759747
[TBL] [Abstract][Full Text] [Related]
20. Effects of IL-12 on the response and susceptibility to experimental viral infections.
Orange JS; Wolf SF; Biron CA
J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
